Company intelligence / Profile preview

Canymed

Leipzig, Saxony, Germany

Ownership: Private
Development stage: Other

Overview

Canymed is a licensed German pharmaceutical wholesaler and manufacturer focused on distribution and development of medical cannabis products, supplying pharmacies, doctors’ practices, and hospitals nationwide under the Grünhorn Group umbrella, including distribution of SOMAÍ cannabinoid-based pharmaceuticals.[1][2][4]

Therapeutic areas: RheumatologyNeurology
Modalities: Small moleculeBiologicPlant extract
Industry: Biotech

Partnerships

SOMAÍ Pharmaceuticals

Beyond the preview

Go deeper on Canymed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canymed.

Explore the full profile